Opis działalności
Bachem is a listed technology-based company focused on peptide chemistry. The company provides a full range of services to the pharma and biotech industries. It specializes in the development of innovative, efficient manufacturing processes and the reliable production of peptide-based active pharmaceutical ingredients. A comprehensive catalog of biochemicals and exclusive custom syntheses for research labs complete the service portfolio. Headquartered in Switzerland with subsidiaries in Europe and the US, the group has a global reach with more experience and know-how than any other company in the industry. Towards its customers, Bachem shows total commitment to quality, innovation and partnership.
Zarząd & Rada nadzorcza
CEO |
Thomas Meier |
Zarząd |
Alain Schaffter, Dr. Günther Loidl, Torsten Wohr |
Rada nadzorcza |
Dr. Kuno Sommer, Nicole Grogg Hötzer, Dr. Alex Fässler, Dr. Steffen Lang, Prof. Dr. Helma Wennemers, Dr. h.c. Peter Grogg |
Dane firmy
Nazwa: |
Bachem Holding AG |
Adres: |
Hauptstraße 144,CH-4416 Bubendorf |
Telefon: |
+41-58-595-2020 |
Fax: |
+41-58-595-2040 |
E-mail: |
sales.ch@bachem.com
|
Internet: |
www.bachem.com |
Przemysł: |
Surowce naturalne |
Sektor: |
Chemia |
Podsektor: |
Chemia, Specjalizacja |
Koniec roku finansowego: |
31.12 |
Free float: |
38,00% |
Data IPO: |
22.07.1998 |
Relacje inwestorskie
Nazwa: |
Daniel Grotzky |
Telefon: |
+41-58-595-2021 |
Fax: |
+41-58-595-2043 |
E-mail: |
ir@bachem.com
|